Glaucoma

Results from the EAGLE and ZAP clinical trials provide answers to lingering questions.

Reach past conventional therapies and give alternatives a try

During the Glaucoma 360 annual meeting, Dake K. Heuer, MD, delivered the Shaffer-Hetherington-Hoskins Lecture Keynote address, titled “Risk Factors for Glaucoma Progression.”

More knowledge helps dispel myths in diagnosing and treating this sight-stealing disease.

Modern optometry can provide advanced outcome support to patients with glaucoma.

Employ treatment strategies that control both conditions with less reliance on drops.

Early and correct diagnosis of this congenital retinal vasculopathy vital to improve visual outcomes.

This carotenoid helps with dry eye, glaucoma, AMD, eye fatigue, and more.

Retinoschisis can make diagnosing open-angle glaucoma especially difficult for optometrists.

Epiretinal membranes can affect accuracy of a glaucooma diagnosis and disease monitoring

Look beyond intraocular pressure for diagnosis and treatment

Good communication is key when it comes to keeping patient needs at the forefront of care.

A rapid-fire view of 2019’s best innovations in optometry- that stood out the most to ODs.

Misdiagnosing neuropathy and over-reliance on OCT imaging results are two examples